Skip to main content
. 2021 Oct 1;12:730289. doi: 10.3389/fimmu.2021.730289

Figure 2.

Figure 2

The effects of tryptophan metabolism in cancer cell and its microenvironment. (A) Tryptophan metabolism mediated by IDO1 and TDO could promote the migration and invasion of glioma cells via Kyn/AHR signaling pathway. IL4I1 catabolizes tryptophan into indole-3-pyruvate (I3P) to inhibit ferroptosis by expressing anti-oxidative gene expression program in Hela cells. IDO1 is induced as an undesired effect of chemotherapy in non-small-cell lung cancer and breast cancer. (B) Tryptophan metabolism suppresses T cell proliferation and function by inducing the differentiation of regulatory T cells (Tregs), the expression of programmed cell death protein 1 (PD1) on CD8+ T cells, cell death of CD8+ T cells and the recruitment of immunosuppressive tumor-associated macrophages. EMT, epithelial-mesenchymal transition.